Loading clinical trials...
Loading clinical trials...
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy Phase I/II
Conditions
Interventions
Rituximab
Locations
2
United States
Rona Z. Silkiss, MD, FACS
Oakland, California, United States
Simeon A. Lauer, MD
New York, New York, United States
Start Date
December 1, 2006
Primary Completion Date
March 1, 2009
Completion Date
March 1, 2009
Last Updated
October 6, 2010
Lead Sponsor
Silkiss, Rona Z., M.D., FACS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions